Tectonic Therapeutic TECX
NASDAQ TECX
$30.75 +0.83 (+2.77%)
As of: Sep 4, 2026 · 3:59 PM EDT

Tectonic Therapeutic (TECX) Current Leases (2022 - 2026)

Tectonic Therapeutic (TECX) posted quarterly Current Leases of $1.2 million for Q1 2026, down 37.78% year-over-year from $1.9 million in Q1 2025, and up 31.16% quarter-over-quarter from $889000.0 in Q4 2025.

Analysis

Tectonic Therapeutic (TECX) Current Leases (2022 - 2026) Analysis & Trends

Tectonic Therapeutic (TECX) has reported Current Leases for 5 consecutive years, with $1.2 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Current Leases fell 37.78% year-over-year to $1.2 million; the TTM figure through Mar 2026 stood at $1.2 million (down 37.78% YoY), while the FY2025 annual figure was $889000.0, down 61.26% from the prior year.
  • Current Leases advanced to $1.2 million in Q1 2026 per TECX's latest filing, from $889000.0 in the prior quarter.
  • Across five years, Current Leases topped out at $2.6 million in Q1 2023 and bottomed at $224000.0 in Q1 2024.
  • Historically, Current Leases has averaged $1.3 million across 5 years, with a median of $1.3 million in 2023.
  • Annual changes were most pronounced in 2024 — Current Leases tumbled 91.47% — and 2025, when it jumped 736.61%.
  • Tectonic Therapeutic's Current Leases stood at $999000.0 in 2022, then jumped by 34.93% to $1.3 million in 2023, then jumped by 70.25% to $2.3 million in 2024, then plunged by 61.26% to $889000.0 in 2025, then surged by 31.16% to $1.2 million in 2026.
  • Business Quant data shows TECX's Current Leases at $1.2 million in Q1 2026, $889000.0 in Q4 2025, and $725000.0 in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 720.00 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 11.00 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - 16.75 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 21.95 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 45.93 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 6.27 Mn
10 Tectonic Therapeutic 589.02 Mn 589.02 Mn - -1.58 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -1.58 Mn
Mar 31, 2026 -1.43 Mn
Dec 31, 2025 889,000.00
Sep 30, 2025 725,000.00
Jun 30, 2025 1.31 Mn
Mar 31, 2025 1.87 Mn
Dec 31, 2024 2.30 Mn
Sep 30, 2024 1.47 Mn
Jun 30, 2024 1.43 Mn
Mar 31, 2024 224,000.00
Dec 31, 2023 1.35 Mn
Sep 30, 2023 1.65 Mn
Jun 30, 2023 2.25 Mn
Mar 31, 2023 2.63 Mn
Dec 31, 2022 999,000.00